VieCure, a company offering intelligent software for oncology care, raised $43 million in funding. The investment was led by Mitch Rales, co-founder of venture capital firm Northpond Ventures and Danaher, a corporation behind various environmental, life sciences and biotech solutions.
VieCure’s technology is designed to provide real-time support that expedites precise clinical decision-making and reduces operational barriers. Its digital ecosystem, Halo Intelligence, combines AI informatics, a clinical inference engine and an oncology electronic medical record to help oncologists design personalized, comprehensive care plans.
The company manages care for approximately 30,000 patients across a growing network of practice locations. VieCure will invest its new capital in further expanding this network of community oncology clinics and building out its AI platform.
